Trial · NCT02266797
Effect of Intravenous Corticosteroid Injections on Dysphagia After Cervical Spine Surgery
NCT02266797, Phase 3, Terminated, NYU Langone Health; results first posted 2016-03-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Intravenous Corticosteroid Injections on Dysphagia After Cervical Spine Surgery. Trials, record NCT02266797. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02266797
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Intravenous Corticosteroid Injections on Dysphagia After Cervical Spine Surgery
- NCT number
- NCT02266797
- Status
- Terminated
- Phases
- Phase 3
- Enrollment
- 4 participants, actual
- Lead sponsor
- NYU Langone Health
- Conditions
- Dysphagia After Anterior Cervical Decompression and Fusion of the Spine
- Interventions
- Dexamethasone, Saline
- First posted
- 2014-10-17
- Last updated
- 2018-10-25
- Results first posted
- 2016-03-14
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intravenous Corticosteroids Effect on Post-operative Dysphagia | 12 months | The severity of dysphagia will be evaluated by dysphagia questionnaires and a two week postoperative swallow evaluation by a licensed swallowing expert. If recommended by the swallow evaluation, a videofluoroscopic swallow study (VFSS) will be performed to further evaluate the severity of dysphagia. |
| Primary | The Correlation Between Radiographic Data and the Extent of Dysphagia in Patients. | 12 months | Soft-tissue swelling will be measured by the anterior cervical soft-tissue shadow width on lateral cervical radiographs. The extent of dysphagia will be evaluated by the dysphagia questionnaires, the swallow evaluation, and the VFSS, if necessary. |
| Secondary | The Efficacy of Intravenous Steroids on Aspiration Rates of Patients Undergoing Anterior Cervical Spine Surgery. | 12 months | Aspiration rates will be evaluated by the percentage of patients in each group with post-operative aspiration. |
| Secondary | Examine the Impact of Dexamethasone on the Development of Postoperative Nausea. | Immediate post-operatively | This will be quantified by the visual analogue scale (VAS) questionnaire for nausea and measuring the number of vomiting episodes following surgery. |
| Secondary | Examine the Impact of Dexamethasone on Radicular Pain. | 12 months | This will be quantified by the NDI questionnaire and VAS questionnaire for neck pain and arm pain. |
| Secondary | Examine Whether Intravenous Steroids Affect the Outcomes of Surgery, for Example, Fusion Rates. | 12 months | The outcomes of surgery will be examined through the 1 year post-operative appointment. |
Source ClinicalTrials.gov
Outcomes6
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Intravenous Corticosteroids Effect on Post-operative Dysphagia | 12 months | Data not available due to premature halting of study | ||
| PRIMARY | The Correlation Between Radiographic Data and the Extent of Dysphagia in Patients. | 12 months | Data not available due to premature halting of study | ||
| SECONDARY | The Efficacy of Intravenous Steroids on Aspiration Rates of Patients Undergoing Anterior Cervical Spine Surgery. | 12 months | Data not available due to premature halting of study | ||
| SECONDARY | Examine the Impact of Dexamethasone on the Development of Postoperative Nausea. | Immediate post-operatively | Data not available due to premature halting of study | ||
| SECONDARY | Examine the Impact of Dexamethasone on Radicular Pain. | 12 months | Data not available due to premature halting of study | ||
| SECONDARY | Examine Whether Intravenous Steroids Affect the Outcomes of Surgery, for Example, Fusion Rates. | 12 months | Data not available due to premature halting of study |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Dexamethasone | 1 | |
| Overall Study | STARTED | Saline | 3 | |
| Overall Study | COMPLETED | Dexamethasone | 1 | |
| Overall Study | COMPLETED | Saline | 2 | |
| Overall Study | NOT COMPLETED | Dexamethasone | 0 | |
| Overall Study | NOT COMPLETED | Saline | 1 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Dexamethasone | ||
| Total, all-cause mortality | Saline | ||
| Total, other adverse events | Dexamethasone | 0 | 1 |
| Total, other adverse events | Saline | 0 | 3 |
| Total, serious adverse events | Dexamethasone | 0 | 1 |
| Total, serious adverse events | Saline | 0 | 3 |
Source ClinicalTrials.gov
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Dexamethasone vs Saline: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02266797
GET https://conductscience.org/api/trials/v1/NCT02266797/registered